Assessment of SARS-CoV-2 Seropositivity During the First and Second Viral Waves in 2020 and 2021 Among Canadian Adults

SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic

(2021) Helen Ward et al.   Nature Communications

kinetics of anti-SARS-CoV-2 antibodies over time. Results of 10 month follow up in over 300 seropositive Health Care Workers

(2021) Jose F. Varona et al.   European Journal of Internal Medicine

Considerations in boosting COVID-19 vaccine immune responses

(2021) Philip R Krause et al.   LANCET

SARS-CoV-2 antibody dynamics and transmission from community-wide serological testing in the Italian municipality of Vo’

(2021) Ilaria Dorigatti et al.   Nature Communications

Infection fatality ratio and case fatality ratio of COVID-19

(2021) Guangze Luo et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study

(2020) Marina Pollán et al.   LANCET

Humoral Immune Response to SARS-CoV-2 in Iceland

(2020) Daniel F. Gudbjartsson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Predictors of self-reported symptoms and testing for COVID-19 in Canada using a nationally representative survey

(2020) Daphne C. Wu et al.   PLoS One

Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis

(2020) Diana Buitrago-Garcia et al.   PLOS MEDICINE

Multicenter Evaluation of the Clinical Performance and the Neutralizing Antibody Activity Prediction Properties of ten high throughput serological assays used in Clinical Laboratories.

(2020) C Therrien et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Towards an accurate and systematic characterisation of persistently asymptomatic infection with SARS-CoV-2

(2020) Eric A Meyerowitz et al.   LANCET INFECTIOUS DISEASES

Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission

(2020) Hannah Peckham et al.   Nature Communications

Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020

(2020) Kristina L. Bajema et al.   JAMA Internal Medicine